期刊文献+

脓毒症患者血清白介素-6的表达及其意义 被引量:13

Expression Level of Serum IL-6 in Septic Patients
下载PDF
导出
摘要 目的探讨脓毒症患者血清白介素-6(IL-6)的表达及其意义。方法选取脓毒症患者99例(脓毒症组),根据有无多器官功能障碍综合征(MODS),分为MODS组16例和非MODS组83例,根据预后分为存活组94例和死亡组5例。同时选取体检正常者为对照组21例。采用酶联免疫吸附实验(ELISA)方法,检测不同时间段不同严重程度脓毒症患者血清IL-6水平。结果脓毒症组入院时及入院后第1、3、5、7天IL-6水平较对照组均明显升高,差异有统计学意义(P<0.05)。MODS组入院后第3、5、7、14天IL-6水平较非MODS组均明显升高,差异有统计学意义(P<0.05)。死亡组入院后第5、7、14天IL-6水平较存活组均明显升高,差异有统计学意义(P<0.05)。结论血清IL-6水平可以作为脓毒症和MODS判断严重程度和预后的一个敏感指标,在危重患者中IL-6可以持续长时间高水平的表达。 Objective To investigate the expression level of serum IL-6 septic patients.Methods A total of 99 septic patients including 16 patients with multiple organ dysfunction syndrome(MODS)(MODS group)and 83 patients without MODS(non-MODS group)were included in this study.In addition,according to the outcomes,they were also divided into survival group(n=94)and death group(n=5).In addition,21 normal controls were enrolled(control group).The serum IL-6 level was detected by enzyme-linked immunosorbent assay(ELISA).Results Serum IL-6 significantly increased in sepsis group than in control group at admission and 1,3,5,and 7 days after admission(all P〈0.05).The expression of IL-6 level was significantly higher in MODS group than in non-MODS group 3,5,7,and 14 days after admission(all P〈0.05),and was significantly higher in death group than in survival group 5,7,and 14 days after admission(all P〈0.05).Conclusion IL-6 can maintain a persistent and high expression in the serum of critically ill patients.It can as a sensitive indicator for predicting the severity and prognosis of sepsis and MODS.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第32期3600-3602,共3页 Chinese General Practice
关键词 脓毒症 多器官功能衰竭 白介素-6 Sepsis Multiple organ failure Interleukin-6
  • 相关文献

参考文献6

  • 1Baue AE,Durham R,Faist E.Systemic inflammatory response syndrome (SIRS),multiple organ dysfunction syndrome(MODS),multiple organ failure:are we winning battle?[J].Shock,1998,10(2):79-89. 被引量:1
  • 2Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM consensus conference committee.American college of chest physicians/society of critical care medicine[J].Chest,1992,101(6):1644-1655. 被引量:1
  • 3Dinarello CA.Proinflammatory cytokines[J].Chest,2000,118(2):503-508. 被引量:1
  • 4Lin E,Lowry SF.Inflammatory cytokines in major surgery:a functional perspective[J].Intensive Care Med,1999,25(3):255-257. 被引量:1
  • 5Oberholzer A,Oberholzer C,Moldawer LL.Sepsis syndromes:understanding the role of innate and acquired immunity[J].Shock,2001,16(2):83-96. 被引量:1
  • 6Polk HC Jr,Shields CL.Remote organ failure:a valid sign of occult intra-abdominal infection[J].Surgery,1977,81(3):310-313. 被引量:1

同被引文献153

引证文献13

二级引证文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部